Swiss nanotech predictions

but not all believe the hype

Written byJane Burgermeister
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The medical benefits long promised from the field of nanotechnology should begin revolutionizing the way disease is diagnosed by 2010, according to an independent study commissioned by the Swiss government.

The Centre for Technology Assessment, TA-SWISS, asked 70 experts from the Unites States and Europe to give their views on where nanotechnology research is now and where it might be in 10 to 20 years' time.

The experts forecast that nanotechnology will lead to more efficient medical diagnosis as early as 2010. “Diagnosis will be quicker, earlier, and much more accurate; that is what the experts believe,” Marcel Indermühle, TA-SWISS nanotechnology project co-coordinator, told The Scientist.

On the other hand, the experts predict that using nanotechnology to treat illnesses could still be more than a decade away. It will also be restricted to specific illnesses, such as cancer and viral infections.

The study by TA-SWISS also addressed fears about the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
December digest cover image of a wooden sculpture comprised of multiple wooden neurons that form a seahorse.
December 2025, Issue 1

Wooden Neurons: An Artistic Vision of the Brain

A neurobiologist, who loves the morphology of cells, turns these shapes into works of art made from wood.

View this Issue
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

Merck
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

MilliporeSigma purple logo
Human iPSC-derived Models for Brain Disease Research

Human iPSC-derived Models for Neurodegenerative Disease Research

Fujifilm
Abstract wireframe sphere with colorful dots and connecting lines representing the complex cellular and molecular interactions within the tumor microenvironment.

Exploring the Inflammatory Tumor Microenvironment 

Cellecta logo

Products

brandtech logo

BRANDTECH® Scientific Announces Strategic Partnership with Copia Scientific to Strengthen Sales and Service of the BRAND® Liquid Handling Station (LHS) 

Top Innovations 2026 Contest Image

Enter Our 2026 Top Innovations Contest

Biotium Logo

Biotium Expands Tyramide Signal Amplification Portfolio with Brighter and More Stable Dyes for Enhanced Spatial Imaging

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS